Multiple Roles of Paeoniflorin in Alzheimer’s Disease

Author:

Meng Zeyu1ORCID,Chen Huize2ORCID,Deng Chujun2ORCID,Meng Shengxi2ORCID

Affiliation:

1. The Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China

2. Department of Traditional Chinese Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China

Abstract

Alzheimer’s disease (AD) is a geriatric disease with the morbidity and mortality continuing to grow, partly due to the aging of the world population. As one of the most common types of primary neurodegenerative dementia, it is mainly due to environmental, epigenetic, immunological, and genetic factors. Paeoniflorin (PF), the main component of paeony extract, plays a more and more important role in the prevention and treatment of AD, including regulating protein, anti-inflammation, antioxidation, and antiapoptosis, protecting glial cells, regulating neurotransmitters and related enzymes and receptors, and inhibiting or activating related signal pathways. This article summarizes the latest researches on the multiple effects and the mechanisms of PF in the treatment to cure AD, providing new insights and research basis for further clinical application of traditional Chinese medicine (TCM) in the treatment of AD.

Funder

Science and Technology Commission of Shanghai Municipality

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

Reference91 articles.

1. Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons

2. The role of amyloids in Alzheimer's and Parkinson's diseases

3. Phosphorylated tau interactome in the human Alzheimer’s disease brain

4. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

5. Analysis of Dihuang Yinzi prescription in treating Alzheimer disease and Parkinson disease based on network pharmacology and molecular docking;N. Liu;Chinese Journal of Information on Traditional Chinese Medicine,2021

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3